| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention relates to compounds intended for treatment of hepatitis C of formula:its stereoisomeric forms, pharmaceutically acceptable salts or solvates, where Rrepresents hydrogen; Rrepresents hydrogen, napthyl or phenyl, optionally substituted with 1, 2 or 3 substituents, selected from halogen and C-Calkyl; Rand Rrepresent hydrogen or C-Calkyl; Rrepresents C-Calkyl, optionally substituted with C-Calkoxygroup, C-Ccycloalkyl or benzyl; Rrepresents hydrogen.EFFECT: claimed are novel compounds and composition on their base, effective against hepatitis C.12 cl, 4 ex, 1 tbl |
